speb/financial-data huggingface dataset:
SURG income_statement (annual, 2024-12-31) — Insurance And Claims: 1096027.00
SURG income_statement (annual, 2024-12-31) — Interest Expense: 554200.00
SURG income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 554200.00
SURG income_statement (annual, 2024-12-31) — Interest Income: 105395.00
SURG income_statement (annual, 2024-12-31) — Interest Income Non Operating: 105395.00
SURG cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 470208.00
SURG balance_sheet (annual, 2024-12-31) — Inventory: 1781365.00
SURG balance_sheet (annual, 2024-12-31) — Invested Capital: 19340970.00
SURG cash_flow (annual, 2024-12-31) — Investing Cash Flow: -3004576.00
SURG balance_sheet (annual, 2024-12-31) — Investments And Advances: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 0.00
SURG balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 0.00
SURG cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 17249994.00
SURG cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
SURG balance_sheet (annual, 2024-12-31) — Leases: 306311.00
SURG balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 319232.00
SURG balance_sheet (annual, 2024-12-31) — Long Term Debt: 2335684.00
SURG balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2654916.00
SURG cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
SURG cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1538776.00
SURG balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
SURG balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (annual, 2024-12-31) — Minority Interest: -54306.00
SURG income_statement (annual, 2024-12-31) — Minority Interests: 208550.00
SURG cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -2500000.00
SURG cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 16618027.00
SURG income_statement (annual, 2024-12-31) — Net Income: -45729224.00
SURG income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -45729224.00
SURG income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -45937774.00
SURG income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -45729224.00
SURG income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -45729224.00
SURG cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -45937774.00
SURG income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -45937774.00
SURG income_statement (annual, 2024-12-31) — Net Interest Income: -448805.00
SURG cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 13613.00
SURG cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 10082119.00
SURG cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -1538776.00
SURG cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -1538776.00
SURG income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -448805.00
SURG cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1395000.00
SURG cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
SURG balance_sheet (annual, 2024-12-31) — Net PPE: 1155869.00
SURG cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -518189.00
SURG cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 0.00
SURG balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 10542957.00
SURG balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 0.00
SURG balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 0.00
SURG balance_sheet (annual, 2024-12-31) — Non Current Note Receivables: 176851.00
SURG balance_sheet (quarterly, 2024-12-31) — Non Current Note Receivables: 176851.00
SURG income_statement (annual, 2024-12-31) — Normalized EBITDA: -39713974.00
SURG income_statement (annual, 2024-12-31) — Normalized Income: -44538417.50
SURG cash_flow (annual, 2024-12-31) — Operating Cash Flow: -21310603.00
SURG cash_flow (annual, 2024-12-31) — Operating Gains Losses: -47477.00
SURG cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -13613.00
SURG income_statement (annual, 2024-12-31) — Operating Income: -41782351.00
SURG income_statement (annual, 2024-12-31) — Operating Revenue: 60881173.00
SURG balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 20068929.00
SURG balance_sheet (annual, 2024-12-31) — Other Current Assets: 298360.00
SURG balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 1689367.00
SURG income_statement (annual, 2024-12-31) — Other Gand A: 10482559.00
SURG income_statement (annual, 2024-12-31) — Other Income Expense: -836618.00
SURG income_statement (quarterly, 2024-12-31) — Other Income Expense: -1437645.00
SURG balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 1472962.00
SURG cash_flow (annual, 2024-12-31) — Other Non Cash Items: 146831.00
SURG cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -118762.00
SURG income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 636868.00
SURG income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -239.00
SURG balance_sheet (annual, 2024-12-31) — Other Properties: 564781.00
SURG income_statement (annual, 2024-12-31) — Other Special Charges: 194863.00
SURG income_statement (quarterly, 2024-12-31) — Other Special Charges: 1.00
SURG balance_sheet (annual, 2024-12-31) — Payables: 4122040.00
SURG balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 4122040.00
SURG income_statement (annual, 2024-12-31) — Pretax Income: -43067774.00
SURG cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 8799257.00
SURG cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
SURG balance_sheet (annual, 2024-12-31) — Properties: 0.00
SURG income_statement (annual, 2024-12-31) — Provision For Doubtful Accounts: 0.00
SURG cash_flow (annual, 2024-12-31) — Purchase Of Business: -2500000.00
SURG cash_flow (annual, 2024-12-31) — Purchase Of Investment: -10159444.00
SURG cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -90938.00
SURG cash_flow (annual, 2024-12-31) — Purchase Of PPE: -518189.00
SURG cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: 0.00
SURG balance_sheet (annual, 2024-12-31) — Receivables: 3000209.00
SURG income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 75078401.00
SURG income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1292250.00
SURG cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1538776.00
SURG cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -631967.00
SURG cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: -146836.00
SURG balance_sheet (annual, 2024-12-31) — Restricted Cash: 1000000.00
SURG balance_sheet (annual, 2024-12-31) — Retained Earnings: -60915427.00
SURG income_statement (annual, 2024-12-31) — Salaries And Wages: 14605283.00
SURG cash_flow (annual, 2024-12-31) — Sale Of Investment: 10173057.00
SURG income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 109004.00
SURG income_statement (annual, 2024-12-31) — Selling General And Administration: 26292873.00
SURG balance_sheet (annual, 2024-12-31) — Share Issued: 20431549.00
SURG income_statement (annual, 2024-12-31) — Special Income Charges: -1876512.00
SURG income_statement (quarterly, 2024-12-31) — Special Income Charges: -1681650.00
SURG cash_flow (annual, 2024-12-31) — Stock Based Compensation: 8361899.00
SURG balance_sheet (annual, 2024-12-31) — Stockholders Equity: 15315919.00
SURG balance_sheet (annual, 2024-12-31) — Tangible Book Value: 10542957.00
SURG income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -316543.50
SURG income_statement (annual, 2024-12-31) — Tax Provision: 2870000.00
SURG income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
SURG balance_sheet (annual, 2024-12-31) — Total Assets: 23976005.00
SURG balance_sheet (annual, 2024-12-31) — Total Capitalization: 17651603.00
SURG balance_sheet (annual, 2024-12-31) — Total Debt: 4592352.00
SURG balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 15261613.00
SURG income_statement (annual, 2024-12-31) — Total Expenses: 102663524.00
SURG balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 8714392.00
SURG balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 6105682.00
SURG balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2654916.00
SURG income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -43464000.00
SURG balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
SURG balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
SURG income_statement (annual, 2024-12-31) — Total Unusual Items: -1507350.00
SURG income_statement (quarterly, 2024-12-31) — Total Unusual Items: -1437406.00
SURG income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1507350.00
SURG income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1437406.00
SURG balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 362620.00
SURG balance_sheet (annual, 2024-12-31) — Treasury Stock: 631967.00
SURG balance_sheet (annual, 2024-12-31) — Working Capital: 11810847.00
SURG income_statement (annual, 2024-12-31) — Write Off: 498273.00
SURG income_statement (quarterly, 2025-03-31) — +Operating Expense: 4637557.00
SURG income_statement (quarterly, 2025-03-31) — +Total Revenue: 10577429.00
SURG balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3760820.00
SURG balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2486889.00
SURG balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1102261.00
SURG balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 76997997.00
SURG balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 163452.00
SURG cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 163452.00
SURG income_statement (quarterly, 2025-03-31) — Basic Average Shares: 20068929.00
SURG income_statement (quarterly, 2025-03-31) — Basic EPS: -0.38
SURG cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 12790389.00
SURG cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -18590.00
SURG balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 507274.00
SURG balance_sheet (quarterly, 2025-03-31) — Capital Stock: 20435.00
SURG balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5397770.00
SURG balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5397770.00
SURG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -410545.00
SURG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -18590.00
SURG cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -6963484.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -361220.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Income Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -60027.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Payable: -361220.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -361220.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 113764.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Receivables: 513320.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 205837.00
SURG cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 513320.00
SURG cash_flow (quarterly, 2025-03-31) — Changes In Cash: -7392619.00
SURG balance_sheet (quarterly, 2025-03-31) — Common Stock: 20435.00
SURG balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 7835954.00
SURG cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -2769.00
SURG income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 13519775.00
SURG balance_sheet (quarterly, 2025-03-31) — Current Assets: 9850620.00
SURG balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 248069.00
SURG balance_sheet (quarterly, 2025-03-31) — Current Debt: 1731366.00
SURG balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1979435.00
SURG balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5740255.00
SURG cash_flow (quarterly, 2025-03-31) — Depreciation: 147401.00
SURG cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 310853.00
SURG income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 86122.00
SURG cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 310853.00
SURG income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 86122.00
SURG income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 20068929.00
SURG income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.38
SURG income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -7635084.00
SURG balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 0.00
SURG income_statement (quarterly, 2025-03-31) — EBIT: -7515859.00
SURG income_statement (quarterly, 2025-03-31) — EBITDA: -7205006.00
SURG income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (quarterly, 2025-03-31) — End Cash Position: 5397770.00
SURG cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -410545.00
SURG cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -6982074.00
SURG income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 4527955.00
SURG balance_sheet (quarterly, 2025-03-31) — Goodwill: 3300000.00
SURG balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 4609510.00
SURG balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2486889.00
SURG balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2129319.00
SURG income_statement (quarterly, 2025-03-31) — Gross Profit: -2942346.00
SURG cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
SURG income_statement (quarterly, 2025-03-31) — Insurance And Claims: 283202.00
SURG income_statement (quarterly, 2025-03-31) — Interest Expense: 119434.00
SURG income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 119434.00
SURG income_statement (quarterly, 2025-03-31) — Interest Income: 56903.00
SURG income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 56903.00
SURG cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 908760.00
SURG balance_sheet (quarterly, 2025-03-31) — Inventory: 1781365.00
SURG balance_sheet (quarterly, 2025-03-31) — Invested Capital: 11450460.00
SURG cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -18590.00
SURG cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
SURG balance_sheet (quarterly, 2025-03-31) — Leases: 324901.00
SURG balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 259205.00
SURG balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1883140.00
SURG balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2142345.00
SURG cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -407776.00
SURG balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (quarterly, 2025-03-31) — Minority Interest: -54515.00
SURG income_statement (quarterly, 2025-03-31) — Minority Interests: 209.00
SURG cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -2769.00
SURG income_statement (quarterly, 2025-03-31) — Net Income: -7635084.00
SURG income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -7635084.00
SURG income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -7635293.00
SURG income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -7635084.00
SURG income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -7635084.00
SURG cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -7635293.00
SURG income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -7635293.00
SURG income_statement (quarterly, 2025-03-31) — Net Interest Income: -62531.00
SURG cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -407776.00
SURG cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -407776.00
SURG income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -62531.00
SURG balance_sheet (quarterly, 2025-03-31) — Net PPE: 1027058.00
SURG cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -18590.00
SURG balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3226444.00
SURG balance_sheet (quarterly, 2025-03-31) — Non Current Note Receivables: 176851.00
SURG income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -7205006.00
SURG income_statement (quarterly, 2025-03-31) — Normalized Income: -7635084.00
SURG cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -6963484.00
SURG income_statement (quarterly, 2025-03-31) — Operating Income: -7579903.00
SURG income_statement (quarterly, 2025-03-31) — Operating Revenue: 10577429.00
SURG balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 20068929.00
SURG balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 184596.00
SURG balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1731366.00
SURG income_statement (quarterly, 2025-03-31) — Other Gand A: 2514313.00
SURG income_statement (quarterly, 2025-03-31) — Other Income Expense: 7140.00
SURG balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 1309510.00
SURG income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 7140.00
SURG balance_sheet (quarterly, 2025-03-31) — Other Properties: 503502.00
SURG balance_sheet (quarterly, 2025-03-31) — Payables: 3760820.00
SURG balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3760820.00
SURG income_statement (quarterly, 2025-03-31) — Pretax Income: -7635293.00
SURG cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
SURG balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SURG cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -18590.00
SURG balance_sheet (quarterly, 2025-03-31) — Receivables: 2486889.00
SURG income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 13295044.00
SURG income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 310853.00
SURG cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -407776.00
SURG cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -2769.00
SURG balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 0.00
SURG balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -68550511.00
SURG income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1730440.00
SURG income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 23480.00
SURG income_statement (quarterly, 2025-03-31) — Selling General And Administration: 4551435.00
SURG balance_sheet (quarterly, 2025-03-31) — Share Issued: 20431549.00
SURG cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 155119.00
SURG balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 7835954.00
SURG balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3226444.00
SURG income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
SURG income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Assets: 15664039.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 9719094.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Debt: 4121780.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 7781439.00
SURG income_statement (quarterly, 2025-03-31) — Total Expenses: 18157332.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7882600.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5813419.00
SURG balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2142345.00
SURG income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -7579902.00
SURG balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 362620.00
SURG balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 631967.00
SURG balance_sheet (quarterly, 2025-03-31) — Working Capital: 4110365.00
SURG income_statement (quarterly, 2025-06-30) — +Operating Expense: 4155843.00
SURG income_statement (quarterly, 2025-06-30) — +Total Revenue: 11518166.00
SURG balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5108402.00
SURG balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2680713.00
SURG balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -1168622.00
SURG balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 77360756.00
SURG balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 163754.00
SURG cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 163754.00
SURG income_statement (quarterly, 2025-06-30) — Basic Average Shares: 19889442.00
SURG income_statement (quarterly, 2025-06-30) — Basic EPS: -0.36
SURG cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5397770.00
SURG balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 446249.00
SURG balance_sheet (quarterly, 2025-06-30) — Capital Stock: 20435.00
SURG balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4404449.00
SURG balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4404449.00
SURG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 5125614.00
SURG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -6118935.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1347582.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Income Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Inventory: -629452.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -61025.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Payable: 1347582.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1347582.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -13807.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Receivables: -193824.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 449474.00
SURG cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -193824.00
SURG cash_flow (quarterly, 2025-06-30) — Changes In Cash: -993321.00
SURG balance_sheet (quarterly, 2025-06-30) — Common Stock: 20435.00
SURG balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 116116.00
SURG cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
SURG income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 14172832.00
SURG balance_sheet (quarterly, 2025-06-30) — Current Assets: 9694382.00
SURG balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 248069.00
SURG balance_sheet (quarterly, 2025-06-30) — Current Debt: 3345598.00
SURG balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3593667.00
SURG balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 8702069.00
SURG cash_flow (quarterly, 2025-06-30) — Depreciation: 128638.00
SURG cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 292392.00
SURG income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 229817.00
SURG cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 292392.00
SURG income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 229817.00
SURG income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 19889442.00
SURG income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.36
SURG income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -7082598.00
SURG balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 0.00
SURG income_statement (quarterly, 2025-06-30) — EBIT: -6803501.00
SURG income_statement (quarterly, 2025-06-30) — EBITDA: -6511109.00
SURG income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (quarterly, 2025-06-30) — End Cash Position: 4404449.00
SURG cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 5125614.00
SURG cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -6118935.00
SURG income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3911883.00
SURG balance_sheet (quarterly, 2025-06-30) — Goodwill: 3300000.00
SURG balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 4445756.00
SURG balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 2680713.00
SURG balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2067042.00
SURG income_statement (quarterly, 2025-06-30) — Gross Profit: -2654666.00
SURG cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
SURG income_statement (quarterly, 2025-06-30) — Insurance And Claims: 283377.00
SURG income_statement (quarterly, 2025-06-30) — Interest Expense: 279306.00
SURG income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 279306.00
SURG income_statement (quarterly, 2025-06-30) — Interest Income: 7008.00
SURG income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 7008.00
SURG cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: -720516.00
SURG balance_sheet (quarterly, 2025-06-30) — Inventory: 2410817.00
SURG balance_sheet (quarterly, 2025-06-30) — Invested Capital: 9715482.00
SURG cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
SURG cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 6000000.00
SURG balance_sheet (quarterly, 2025-06-30) — Leases: 324901.00
SURG balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 198180.00
SURG balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 6253768.00
SURG balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6451948.00
SURG cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 6000000.00
SURG cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -282155.00
SURG balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (quarterly, 2025-06-30) — Minority Interest: -54724.00
SURG income_statement (quarterly, 2025-06-30) — Minority Interests: 209.00
SURG cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 2769.00
SURG balance_sheet (quarterly, 2025-06-30) — Net Debt: 5194917.00
SURG income_statement (quarterly, 2025-06-30) — Net Income: -7082598.00
SURG income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -7082598.00
SURG income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -7082807.00
SURG income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -7082598.00
SURG income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -7082598.00
SURG cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -7082807.00
SURG income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -7082807.00
SURG income_statement (quarterly, 2025-06-30) — Net Interest Income: -272298.00
SURG cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 5717845.00
SURG cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 5717845.00
SURG income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -272298.00
SURG balance_sheet (quarterly, 2025-06-30) — Net PPE: 898420.00
SURG balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -4329640.00
SURG balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 176851.00
SURG income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6511109.00
SURG income_statement (quarterly, 2025-06-30) — Normalized Income: -7082598.00
SURG cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6118935.00
SURG income_statement (quarterly, 2025-06-30) — Operating Income: -6810509.00
SURG income_statement (quarterly, 2025-06-30) — Operating Revenue: 11518166.00
SURG balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 20068929.00
SURG balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 198403.00
SURG balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 3345598.00
SURG income_statement (quarterly, 2025-06-30) — Other Gand A: 1814237.00
SURG balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1145756.00
SURG balance_sheet (quarterly, 2025-06-30) — Other Properties: 441225.00
SURG balance_sheet (quarterly, 2025-06-30) — Payables: 5108402.00
SURG balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 5108402.00
SURG income_statement (quarterly, 2025-06-30) — Pretax Income: -7082807.00
SURG cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
SURG balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
SURG balance_sheet (quarterly, 2025-06-30) — Receivables: 2680713.00
SURG income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 14110257.00
SURG income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 292392.00
SURG cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -282155.00
SURG balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 0.00
SURG balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -75633109.00
SURG income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1814269.00
SURG income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 14143.00
SURG income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3926026.00
SURG balance_sheet (quarterly, 2025-06-30) — Share Issued: 20431549.00
SURG cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 155119.00
SURG balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 116116.00
SURG balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -4329640.00
SURG income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
SURG income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Assets: 15215409.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6369884.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Debt: 10045615.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 61392.00
SURG income_statement (quarterly, 2025-06-30) — Total Expenses: 18328675.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 15154017.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 5521027.00
SURG balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6451948.00
SURG income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -6810509.00
SURG balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 695953.00
SURG balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 1631966.00
SURG balance_sheet (quarterly, 2025-06-30) — Working Capital: 992313.00
SURG income_statement (quarterly, 2025-09-30) — +Operating Expense: 4353568.00
SURG income_statement (quarterly, 2025-09-30) — +Total Revenue: 18680317.00
SURG balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8335599.00
SURG balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4291222.00
SURG balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1195465.00
SURG balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 78363849.00
SURG balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: -327206.00
SURG cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: -327206.00
SURG income_statement (quarterly, 2025-09-30) — Basic Average Shares: 19839159.00
SURG income_statement (quarterly, 2025-09-30) — Basic EPS: -0.38
SURG cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4404449.00
SURG balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 384188.00
SURG balance_sheet (quarterly, 2025-09-30) — Capital Stock: 20765.00
SURG balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2514862.00
SURG balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2514862.00
SURG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2756799.00
SURG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -4646386.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 3492893.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Inventory: 493200.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -62061.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Payable: 3492893.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 3492893.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -80129.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1610509.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 2233394.00
SURG cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1610509.00
SURG cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1889587.00
SURG balance_sheet (quarterly, 2025-09-30) — Common Stock: 20765.00
SURG balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -6369529.00
SURG cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 649383.00
SURG income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 21276771.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Assets: 9227180.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 227005.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Debt: 8911202.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9138207.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 17674046.00
SURG balance_sheet (quarterly, 2025-09-30) — Current Notes Payable: 1822426.00
SURG cash_flow (quarterly, 2025-09-30) — Depreciation: 580512.00
SURG cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 253306.00
SURG income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 190291.00
SURG cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 253306.00
SURG income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 190291.00
SURG income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 19839159.00
SURG income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.38
SURG income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7489068.00
SURG balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 200240.00
SURG income_statement (quarterly, 2025-09-30) — EBIT: -6950138.00
SURG income_statement (quarterly, 2025-09-30) — EBITDA: -6696832.00
SURG income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 0.00
SURG cash_flow (quarterly, 2025-09-30) — End Cash Position: 2514862.00
SURG cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2756799.00
SURG cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -4646386.00
SURG income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4086329.00
SURG balance_sheet (quarterly, 2025-09-30) — Goodwill: 3300000.00
SURG balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4282606.00
SURG balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 4291222.00
SURG balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2003729.00
SURG income_statement (quarterly, 2025-09-30) — Gross Profit: -2596454.00
SURG cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
SURG income_statement (quarterly, 2025-09-30) — Insurance And Claims: 260579.00
SURG income_statement (quarterly, 2025-09-30) — Interest Expense: 539157.00
SURG income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 539157.00
SURG income_statement (quarterly, 2025-09-30) — Interest Income: 0.00
SURG income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 76266.00
SURG balance_sheet (quarterly, 2025-09-30) — Inventory: 1917617.00
SURG balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5629825.00
SURG cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 649383.00
SURG cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 2974698.00
SURG balance_sheet (quarterly, 2025-09-30) — Leases: 324901.00
SURG balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 157183.00
SURG balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 3088152.00
SURG balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3245335.00
SURG cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 2974698.00
SURG cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -800902.00
SURG balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 1300916.00
SURG balance_sheet (quarterly, 2025-09-30) — Minority Interest: -54951.00
SURG income_statement (quarterly, 2025-09-30) — Minority Interests: 227.00
SURG cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 649383.00
SURG balance_sheet (quarterly, 2025-09-30) — Net Debt: 9484492.00
SURG income_statement (quarterly, 2025-09-30) — Net Income: -7489068.00
SURG income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7489068.00
SURG income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7489295.00
SURG income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7489068.00
SURG income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7489068.00
SURG cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7489295.00
SURG income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7489295.00
SURG income_statement (quarterly, 2025-09-30) — Net Interest Income: -539157.00
SURG cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 2173796.00
SURG cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 2173796.00
SURG income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -539157.00
SURG cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -66380.00
SURG balance_sheet (quarterly, 2025-09-30) — Net PPE: 808264.00
SURG balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -10652135.00
SURG balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 176851.00
SURG income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -6696832.00
SURG income_statement (quarterly, 2025-09-30) — Normalized Income: -7489068.00
SURG cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -4646386.00
SURG income_statement (quarterly, 2025-09-30) — Operating Income: -6950022.00
SURG income_statement (quarterly, 2025-09-30) — Operating Revenue: 18680317.00
SURG balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20065278.00
SURG balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 278532.00
SURG balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 7088776.00
SURG income_statement (quarterly, 2025-09-30) — Other Gand A: 1970891.00
SURG balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 982606.00
SURG cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 140322.00
SURG balance_sheet (quarterly, 2025-09-30) — Other Properties: 377912.00
SURG balance_sheet (quarterly, 2025-09-30) — Payables: 8535839.00
SURG balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 8535839.00
SURG income_statement (quarterly, 2025-09-30) — Pretax Income: -7489295.00
SURG cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
SURG balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
SURG balance_sheet (quarterly, 2025-09-30) — Receivables: 4291222.00
SURG income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 21213756.00
SURG income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 253306.00
SURG cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -800902.00
SURG balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 224947.00
SURG balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -83122177.00
SURG income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1854859.00
SURG income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 76948.00
SURG income_statement (quarterly, 2025-09-30) — Selling General And Administration: 4163277.00
SURG balance_sheet (quarterly, 2025-09-30) — Share Issued: 20761231.00
SURG income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
SURG cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 215887.00
SURG balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -6369529.00
SURG balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -10652135.00
SURG income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
SURG income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
SURG income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Assets: 14494901.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -3281377.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Debt: 12383542.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -6424480.00
SURG income_statement (quarterly, 2025-09-30) — Total Expenses: 25630339.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 20919381.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5267721.00
SURG balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3245335.00
SURG income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -6950138.00
SURG income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
SURG income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SURG balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 695953.00
SURG balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 1631966.00
SURG balance_sheet (quarterly, 2025-09-30) — Working Capital: -8446866.00
SURG income_statement (annual, 2025-12-31) — +Operating Expense: 20071121.00
SURG income_statement (quarterly, 2025-12-31) — +Operating Expense: 6924035.00
SURG income_statement (annual, 2025-12-31) — +Total Revenue: 56962920.00
SURG income_statement (quarterly, 2025-12-31) — +Total Revenue: 16187007.00
SURG balance_sheet (annual, 2025-12-31) — Accounts Payable: 10219011.00
SURG balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 10219011.00
SURG balance_sheet (annual, 2025-12-31) — Accounts Receivable: 4045162.00
SURG balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 4045162.00
SURG balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1222300.00
SURG balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1222300.00
SURG balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 83246736.00
SURG balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 83246736.00
SURG cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 0.00
SURG cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 0.00
SURG cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3476851.00
SURG income_statement (annual, 2025-12-31) — Basic Average Shares: 20085138.00
SURG income_statement (annual, 2025-12-31) — Basic EPS: -1.80
SURG cash_flow (annual, 2025-12-31) — Beginning Cash Position: 12790389.00
SURG cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2514862.00
SURG cash_flow (annual, 2025-12-31) — Capital Expenditure: -18590.00
SURG balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 319232.00
SURG balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 319232.00
SURG balance_sheet (annual, 2025-12-31) — Capital Stock: 21852.00
SURG balance_sheet (quarterly, 2025-12-31) — Capital Stock: 21852.00
SURG balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1731400.00
SURG balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1731400.00
SURG balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1731400.00
SURG balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1731400.00
SURG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 10534564.00
SURG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 3062696.00
SURG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -18590.00
SURG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
SURG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -21293152.00
SURG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -3564347.00
SURG cash_flow (annual, 2025-12-31) — Change In Account Payable: 6279973.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1800718.00
SURG cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: 0.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 0.00
SURG cash_flow (annual, 2025-12-31) — Change In Inventory: 1441795.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Inventory: 1578047.00
SURG cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -248069.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -64956.00
SURG cash_flow (annual, 2025-12-31) — Change In Payable: 6279973.00
SURG cash_flow (quarterly, 2025-12-31) — Change In Payable: 1800718.00